BIOMAT Database Logo BIOMAT Database Logo

Serum erythropoietin levels in patients with sepsis and septic shock. 1996

J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Department of Internal Medicine, University of Bonn, Germany.

The role of the immune system in the control of the production of erythropoietin is still poorly understood. Herein, the levels of circulating immunoreactive erythropoietin, tumour necrosis factor alpha, interleukin-1 beta and interleukin-6 were determined in 10 septic patients for up to 4 d following the admission to an internal intensive care unit. The data show that the production of erythropoietin was not suppressed despite an increase in the levels of proinflammatory cytokines. Circulating erythropoietin and interleukin-6 greatly increased in the 6 nonsurviving patients. The pattern of the serum erythropoietin level in the nonsurvivors resembled that of acute phase proteins and was independent of the blood haemoglobin concentration. Similar to interleukin 6, abnormally high serum erythropoietin levels appear to be a negative prognostic indicator in patients suffering from septic shock.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes

Related Publications

J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum erythropoietin levels in septic shock.
October 2005, Anaesthesia and intensive care,
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum TNF levels in neonatal sepsis and septic shock.
April 1993, Acta paediatrica (Oslo, Norway : 1992),
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum galectin-3 levels predict poor prognosis in sepsis and septic shock patients.
January 2023, Revista da Associacao Medica Brasileira (1992),
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum cardiac troponin I levels in pediatric sepsis/septic shock.
July 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies,
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Mannose-binding lectin serum levels in neonatal sepsis and septic shock.
April 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS data.
June 2017, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum CXCL12 levels on hospital admission predict mortality in patients with severe sepsis/septic shock.
December 2015, The American journal of emergency medicine,
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Serum Cortisol Level in Indian Patients with Severe Sepsis/Septic Shock.
January 2017, Journal of emergencies, trauma, and shock,
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Correlation Between Serum Procalcitonin Levels and 28-Day Mortality in Patients with Surgical Sepsis and Septic Shock.
April 2023, Chirurgia (Bucharest, Romania : 1990),
J Abel, and N Spannbrucker, and J Fandrey, and W Jelkmann
Changes in the serum proteome of patients with sepsis and septic shock.
December 2006, Anesthesia and analgesia,
Copied contents to your clipboard!